نتائج البحث

1

دورية أكاديمية

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes

المؤلفون: Sara Mongiorgi, Alessia De Stefano, Stefano Ratti, Valentina Indio, Annalisa Astolfi, Irene Casalin, Andrea Pellagatti, Stefania Paolini, Sarah Parisi, Michele Cavo, Andrea Pession, James A. McCubrey, Pann-Ghill Suh, Lucia Manzoli, Jacqueline Boultwood, Carlo Finelli, Lucio Cocco, Matilde Y. Follo

المصدر: Clinical Epigenetics, Vol 15, Iss 1, Pp 1-12 (2023)

مصطلحات موضوعية: miRNA profiling, Myelodysplastic syndromes, BCL2, Azacitidine, Lenalidomide, Medicine, Genetics, QH426-470

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1868-7083Test

الوصول الحر: https://doaj.org/article/c109ec95839b4454ba98608885f40f32Test

View record in DOAJ

النص الكامل

2

دورية أكاديمية

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes

المؤلفون: Mongiorgi, Sara, De Stefano, Alessia, Ratti, Stefano, Indio, Valentina, Astolfi, Annalisa, Casalin, Irene, Pellagatti, Andrea, Paolini, Stefania, Parisi, Sarah, Cavo, Michele, Pession, Andrea, McCubrey, James A, Suh, Pann-Ghill, Manzoli, Lucia, Boultwood, Jacqueline, Finelli, Carlo, Cocco, Lucio, Follo, Matilde Y

المساهمون: Mongiorgi, Sara, De Stefano, Alessia, Ratti, Stefano, Indio, Valentina, Astolfi, Annalisa, Casalin, Irene, Pellagatti, Andrea, Paolini, Stefania, Parisi, Sarah, Cavo, Michele, Pession, Andrea, McCubrey, James A, Suh, Pann-Ghill, Manzoli, Lucia, Boultwood, Jacqueline, Finelli, Carlo, Cocco, Lucio, Follo, Matilde Y

مصطلحات موضوعية: Azacitidine, BCL2, Lenalidomide, Myelodysplastic syndrome, miRNA profiling

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36803590; info:eu-repo/semantics/altIdentifier/wos/WOS:000934593400002; volume:15; issue:1; firstpage:1; lastpage:12; numberofpages:12; journal:CLINICAL EPIGENETICS; https://hdl.handle.net/11585/932013Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85148404058; https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-023-01441-9Test

الإتاحة: https://doi.org/10.1186/s13148-023-01441-9Test
https://hdl.handle.net/11585/932013Test

View record in BASE

3

دورية أكاديمية

Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials

المؤلفون: Morabito, Fortunato, Zamagni, Elena, Conticello, Concetta, Pavone, Vincenzo, Palmieri, Salvatore, Bringhen, Sara, Galli, Monica, Mangiacavalli, Silvia, Derudas, Daniele, Rossi, Elena, Ria, Roberto, Catalano, Lucio, Tacchetti, Paola, Mele, Giuseppe, Vincelli, Iolanda Donatella, Martino, Enrica Antonia, Vigna, Ernesto, Bruzzese, Antonella, Mendicino, Francesco, Botta, Cirino, Mele, Anna, Pantani, Lucia, Rocchi, Serena, Garibaldi, Bruno, Cascavilla, Nicola, Ballanti, Stelvio, Tripepi, Giovanni, Frigeri, Ferdinando, Falcone, Antonetta Pia, Cangialosi, Clotilde, Reddiconto, Giovanni, Farina, Giuliana, Barone, Marialucia, Rizzello, Ilaria, Iaccino, Enrico, Mimmi, Selena, Curci, Paola, Gamberi, Barbara, Musto, Pellegrino, De Stefano, Valerio, Musso, Maurizio, Petrucci, Maria Teresa, Offidani, Massimo, Di Raimondo, Francesco, Boccadoro, Mario, Cavo, Michele, Neri, Antonino, Gentile, Massimo

المساهمون: Morabito, Fortunato, Zamagni, Elena, Conticello, Concetta, Pavone, Vincenzo, Palmieri, Salvatore, Bringhen, Sara, Galli, Monica, Mangiacavalli, Silvia, Derudas, Daniele, Rossi, Elena, Ria, Roberto, Catalano, Lucio, Tacchetti, Paola, Mele, Giuseppe, Vincelli, Iolanda Donatella, Martino, Enrica Antonia, Vigna, Ernesto, Bruzzese, Antonella, Mendicino, Francesco, Botta, Cirino, Mele, Anna, Pantani, Lucia, Rocchi, Serena, Garibaldi, Bruno, Cascavilla, Nicola, Ballanti, Stelvio, Tripepi, Giovanni, Frigeri, Ferdinando, Falcone, Antonetta Pia, Cangialosi, Clotilde, Reddiconto, Giovanni, Farina, Giuliana, Barone, Marialucia, Rizzello, Ilaria, Iaccino, Enrico, Mimmi, Selena, Curci, Paola, Gamberi, Barbara, Musto, Pellegrino, De Stefano, Valerio, Musso, Maurizio, Petrucci, Maria Teresa, Offidani, Massimo, Di Raimondo, Francesco, Boccadoro, Mario, Cavo, Michele, Neri, Antonino, Gentile, Massimo

مصطلحات موضوعية: carfilzomib, elotuzumab, lenalidomide, multiple myeloma, prognosi, prognostic score, relapsed/refractory, survival

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35924160; info:eu-repo/semantics/altIdentifier/wos/WOS:000892806100001; volume:12; numberofpages:10; journal:FRONTIERS IN ONCOLOGY; http://hdl.handle.net/10447/567262Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85135230918

الإتاحة: https://doi.org/10.3389/fonc.2022.890376Test
http://hdl.handle.net/10447/567262Test

View record in BASE

4

دورية أكاديمية

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

المؤلفون: Bruzzese, Antonella, Derudas, Daniele, Galli, Monica, Martino, Enrica Antonia, Rocco, Stefano, Conticello, Concetta, Califano, Catello, Giuliani, Nicola, Mangiacavalli, Silvia, Farina, Giuliana, Lombardo, Alessandra, Brunori, Marino, Rossi, Elena, Antonioli, Elisabetta, Ria, Roberto, Zambello, Renato, Di Renzo, Nicola, Mele, Giuseppe, Marcacci, Gianpaolo, Pietrantuono, Giuseppe, Palumbo, Gaetano, Cascavilla, Nicola, Cerchione, Claudio, Belotti, Angelo, Criscuolo, Clelia, Uccello, Giuseppina, Curci, Paola, Vigna, Ernesto, Mendicino, Francesco, Iaccino, Enrico, Mimmi, Selena, Botta, Cirino, Vincelli, Donatella, Sgherza, Nicola, Bonalumi, Angela, Cupelli, Luca, Stocchi, Raffaella, Martino, Massimo, Ballanti, Stelvio, Gangemi, Dominella, Gagliardi, Alfredo, Gamberi, Barbara, Pompa, Alessandra, Tripepi, Giovanni, Frigeri, Ferdinando, Consoli, Ugo, Bringhen, Sara, Zamagni, Elena, Patriarca, Francesca, De Stefano, Valerio, Di Raimondo, Francesco, Palmieri, Salvatore, Petrucci, Maria Teresa, Offidani, Massimo, Musto, Pellegrino, Boccadoro, Mario, Cavo, Michele, Neri, Antonino, Morabito, Fortunato, Gentile, Massimo

المساهمون: A. Bruzzese, D. Deruda, M. Galli, E.A. Martino, S. Rocco, C. Conticello, C. Califano, N. Giuliani, S. Mangiacavalli, G. Farina, A. Lombardo, M. Brunori, E. Rossi, E. Antonioli, R. Ria, R. Zambello, N. Di Renzo, G. Mele, G. Marcacci, G. Pietrantuono, G. Palumbo, N. Cascavilla, C. Cerchione, A. Belotti, C. Criscuolo, G. Uccello, P. Curci, E. Vigna, F. Mendicino, E. Iaccino, S. Mimmi, C. Botta, D. Vincelli, N. Sgherza, A. Bonalumi, L. Cupelli, R. Stocchi, M. Martino, S. Ballanti, D. Gangemi, A. Gagliardi, B. Gamberi, A. Pompa, G. Tripepi, F. Frigeri, U. Consoli, S. Bringhen, E. Zamagni, F. Patriarca, V. De Stefano, F. Di Raimondo, S. Palmieri, M.T. Petrucci, M. Offidani, P. Musto, M. Boccadoro, M. Cavo, A. Neri, F. Morabito, M. Gentile

مصطلحات موضوعية: dexamethasone, elotuzumab, lenalidomide, multiple myeloma, salvage therapy, Settore MED/15 - Malattie del Sangue

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35608183; info:eu-repo/semantics/altIdentifier/wos/WOS:000803830800001; journal:HEMATOLOGICAL ONCOLOGY; http://hdl.handle.net/2434/930455Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85131188016

الإتاحة: https://doi.org/10.1002/hon.3031Test
http://hdl.handle.net/2434/930455Test

View record in BASE

5

دورية أكاديمية

Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials

المؤلفون: Fortunato Morabito, Elena Zamagni, Concetta Conticello, Vincenzo Pavone, Salvatore Palmieri, Sara Bringhen, Monica Galli, Silvia Mangiacavalli, Daniele Derudas, Elena Rossi, Roberto Ria, Lucio Catalano, Paola Tacchetti, Giuseppe Mele, Iolanda Donatella Vincelli, Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Francesco Mendicino, Cirino Botta, Anna Mele, Lucia Pantani, Serena Rocchi, Bruno Garibaldi, Nicola Cascavilla, Stelvio Ballanti, Giovanni Tripepi, Ferdinando Frigeri, Antonetta Pia Falcone, Clotilde Cangialosi, Giovanni Reddiconto, Giuliana Farina, Marialucia Barone, Ilaria Rizzello, Enrico Iaccino, Selena Mimmi, Paola Curci, Barbara Gamberi, Pellegrino Musto, Valerio De Stefano, Maurizio Musso, Maria Teresa Petrucci, Massimo Offidani, Francesco Di Raimondo, Mario Boccadoro, Michele Cavo, Antonino Neri, Massimo Gentile

المصدر: Frontiers in Oncology, Vol 12 (2022)

مصطلحات موضوعية: multiple myeloma, prognosis, prognostic score, carfilzomib, elotuzumab, lenalidomide, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.890376/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/558f55d38b4c4a8a985194fbba17f62dTest

View record in DOAJ

النص الكامل

6

دورية أكاديمية

Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow‐up subgroup analysis of the BOSTON trial.

المؤلفون: Mateos, Maria‐Victoria, Engelhardt, Monika, Leleu, Xavier, Mesa, Mercedes Gironella, Cavo, Michele, Dimopoulos, Meletios, Bianco, Martina, Merlo, Giovanni Marino, Porte, Charles la, Richardson, Paul G., Moreau, Philippe

المصدر: European Journal of Haematology; Aug2024, Vol. 113 Issue 2, p242-252, 11p

مصطلحات موضوعية: MULTIPLE myeloma, BORTEZOMIB, CLINICAL trials, PROTEASOME inhibitors, SUBGROUP analysis (Experimental design)

مصطلحات جغرافية: BOSTON (Mass.)

7

دورية أكاديمية

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial

المساهمون: Gay, Francesca, Musto, Pellegrino, Rota-Scalabrini, Delia, Bertamini, Luca, Belotti, Angelo, Galli, Monica, Offidani, Massimo, Zamagni, Elena, Ledda, Antonio, Grasso, Mariella, Ballanti, Stelvio, Spadano, Antonio, Cea, Michele, Patriarca, Francesca, D'Agostino, Mattia, Capra, Andrea, Giuliani, Nicola, de Fabritiis, Paolo, Aquino, Sara, Palmas, Angelo, Gamberi, Barbara, Zambello, Renato, Petrucci, Maria Teresa, Corradini, Paolo, Cavo, Michele, Boccadoro, Mario

مصطلحات موضوعية: multiple myeloma, newly diagnosed, carfilzomib, cyclophosphamide, lenalidomide, dexamethasone, induction treatment, autologous stem-cell transplantation, maintenance treatment, phase 2, trial

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34774221; info:eu-repo/semantics/altIdentifier/wos/WOS:000729806300028; volume:22; issue:12; firstpage:1705; lastpage:1720; numberofpages:16; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/2318/1819042Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85120322106; https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045Test(21)00535-0/ppt; https://doi.org/10.1016/s1470-2045Test(21)00535-0

الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00535-0
https://doi.org/10.1016/s1470-2045Test(21)00535-0
http://hdl.handle.net/2318/1819042Test
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045Test(21)00535-0/ppt

View record in BASE

8

دورية أكاديمية

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

المؤلفون: Gentile M., Specchia G., Derudas D., Galli M., Botta C., Rocco S., Conticello C., Califano C., Giuliani N., Mangiacavalli S., Attingenti E., Lombardo A., Brunori M., Rossi E., Antonioli E., Ria R., Zambello R., Di Renzo N., Mele G., Marcacci G., Musto P., Capalbo S., Cascavilla N., Cerchione C., Belotti A., Criscuolo C., Uccello G., Curci P., Vigna E., Fraticelli V., Vincelli D., Bonalumi A., Siniscalchi A., Stocchi R., Martino M., Ballanti S., Gangemi D., Gagliardi A., Gamberi B., Pompa A., Recchia A. G., Tripepi G., Pitino A., Frigeri F., Consoli U., Bringhen S., Zamagni E., Patriarca F., De Stefano V., Di Raimondo F., Palmieri S., Petrucci M. T., Offidani M., Boccadoro M., Cavo M., Morabito F.

المساهمون: Gentile M., Specchia G., Derudas D., Galli M., Botta C., Rocco S., Conticello C., Califano C., Giuliani N., Mangiacavalli S., Attingenti E., Lombardo A., Brunori M., Rossi E., Antonioli E., Ria R., Zambello R., Di Renzo N., Mele G., Marcacci G., Musto P., Capalbo S., Cascavilla N., Cerchione C., Belotti A., Criscuolo C., Uccello G., Curci P., Vigna E., Fraticelli V., Vincelli D., Bonalumi A., Siniscalchi A., Stocchi R., Martino M., Ballanti S., Gangemi D., Gagliardi A., Gamberi B., Pompa A., Recchia A.G., Tripepi G., Pitino A., Frigeri F., Consoli U., Bringhen S., Zamagni E., Patriarca F., De Stefano V., Di Raimondo F., Palmieri S., Petrucci M.T., Offidani M., Boccadoro M., Cavo M., Morabito F.

مصطلحات موضوعية: Elotuzumab, lenalidomide, dexamethasone, multiple myeloma

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000623255700006; volume:106; issue:1; firstpage:291; lastpage:294; numberofpages:4; journal:HAEMATOLOGICA; http://hdl.handle.net/10447/513541Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85099006875

الإتاحة: https://doi.org/10.3324/haematol.2019.241513Test
http://hdl.handle.net/10447/513541Test

View record in BASE

9

دورية أكاديمية

Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients

المؤلفون: Morabito, Fortunato, Zamagni, Elena, Conticello, Concetta, Pavone, Vincenzo, Palmieri, Salvatore, Bringhen, Sara, Galli, Monica, Mangiacavalli, Silvia, Derudas, Daniele, Rossi, Elena, Ria, Roberto, Catalano, Lucio, Tacchetti, Paola, Mele, Giuseppe, Vincelli, Iolanda Donatella, Martino, Enrica Antonia, Vigna, Ernesto, Botta, Cirino, Bruzzese, Antonella, Mele, Anna, Pantani, Lucia, Rocchi, Serena, Garibaldi, Bruno, Cascavilla, Nicola, Ballanti, Stelvio, Tripepi, Giovanni, Frigeri, Ferdinando, Falcone, Antonetta Pia, Cangialosi, Clotilde, Reddiconto, Giovanni, Farina, Giuliana, Barone, Marialucia, Rizzello, Ilaria, Musto, Pellegrino, De Stefano, Valerio, Musso, Maurizio, Petrucci, Maria Teresa, Offidani, Massimo, Neri, Antonino, Di Renzo, Nicola, Di Raimondo, Francesco, Boccadoro, Mario, Cavo, Michele, Gentile, Massimo

المساهمون: F. Morabito, E. Zamagni, C. Conticello, V. Pavone, S. Palmieri, S. Bringhen, M. Galli, S. Mangiacavalli, D. Deruda, E. Rossi, R. Ria, L. Catalano, P. Tacchetti, G. Mele, I.D. Vincelli, E.A. Martino, E. Vigna, C. Botta, A. Bruzzese, A. Mele, L. Pantani, S. Rocchi, B. Garibaldi, N. Cascavilla, S. Ballanti, G. Tripepi, F. Frigeri, A.P. Falcone, C. Cangialosi, G. Reddiconto, G. Farina, M. Barone, I. Rizzello, P. Musto, V. De Stefano, M. Musso, M.T. Petrucci, M. Offidani, A. Neri, N. Di Renzo, F. Di Raimondo, M. Boccadoro, M. Cavo, M. Gentile

مصطلحات موضوعية: elotuzumab, carfilzomib, dexamethasone, lenalidomide, multiple myeloma, salvage therapy, Settore MED/15 - Malattie del Sangue

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34716957; info:eu-repo/semantics/altIdentifier/wos/WOS:000716208000001; journal:EUROPEAN JOURNAL OF HAEMATOLOGY; http://hdl.handle.net/2434/880266Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85118784207

الإتاحة: https://doi.org/10.1111/ejh.13723Test
http://hdl.handle.net/2434/880266Test

View record in BASE

10

دورية أكاديمية

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial

المؤلفون: Oliva S., Bruinink D. H., Rihova L., D'Agostino M., Pantani L., Capra A., van der Holt B., Troia R., Petrucci M. T., Villanova T., Vsianska P., Jugooa R., Brandt-Hagens C., Gilestro M., Offidani M., Ribolla R., Galli M., Hajek R., Gay F., Cavo M., Omede P., van der Velden V. H. J., Boccadoro M., Sonneveld P.

المساهمون: Oliva S., Bruinink D.H., Rihova L., D'Agostino M., Pantani L., Capra A., van der Holt B., Troia R., Petrucci M.T., Villanova T., Vsianska P., Jugooa R., Brandt-Hagens C., Gilestro M., Offidani M., Ribolla R., Galli M., Hajek R., Gay F., Cavo M., Omede P., van der Velden V.H.J., Boccadoro M., Sonneveld P.

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocol, Autograft, Bone Marrow Cell, Bortezomib, Dexamethasone, Disease-Free Survival, Female, Human, Lenalidomide, Male, Melphalan, Middle Aged, Neoplasm, Residual, Survival Rate, Flow Cytometry, Hematopoietic Stem Cell Transplantation, Multiple Myeloma

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34083504; info:eu-repo/semantics/altIdentifier/wos/WOS:000657729400001; volume:11; issue:6; firstpage:1; lastpage:9; numberofpages:9; journal:BLOOD CANCER JOURNAL; http://hdl.handle.net/11585/865103Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85107145070; https://www.nature.com/articles/s41408-021-00498-0Test

الإتاحة: https://doi.org/10.1038/s41408-021-00498-0Test
http://hdl.handle.net/11585/865103Test
https://www.nature.com/articles/s41408-021-00498-0Test

View record in BASE

تنقيح النتائج